Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe STEP HFpEF DM study record has moved from results submitted to results posted, with results sections now available, including participant flow, baseline characteristics, outcome measures, and adverse events.SummaryDifference0.6%

- Check14 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition.SummaryDifference0.3%

- Check21 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov interface as revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check28 days agoChange DetectedThe trial record now reports “Results Submitted” instead of “No Results Posted,” indicating that results have been sent to ClinicalTrials.gov but are not necessarily publicly posted yet.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a newer version of the page's documentation.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 in the page header, indicating a small site maintenance or update to the Record History view.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.